Aylvin Dias – VJRegenMed

Progress in creating degradable materials for medical devices

Simon Ng — Thu, 20 Jan 2022 17:55:02 +0000

Aylvin Dias, PhD, DSM, Geleen, The Netherlands, comments on the development of degradable materials in the field of regenerative medicine, which can be applied as a drug delivery device in patients, and will not interfere with the healing response. Dr Dias additionally highlights steps that need to be taken for successful clinical adoption of degradable materials, including initially focusing on one indication, and on the pharmacokinetics of the final products. This interview took place at the 6th World Congress of the Tissue Engineering and Regenerative Medicine International Society (TERMIS 2021).

Comparing materials for personalized wrist implants

Simon Ng — Tue, 18 Jan 2022 18:02:42 +0000

Aylvin Dias, PhD, DSM, Geleen, The Netherlands, provides an overview of the development process for personalized 3D printed wrist implants. Various technologies such as injection molding were explored and were found to be superior to 3D printing, due to 3D printed models not having the required properties required for implants. Safety was an additional concern, with materials used in injection molding having a more established safety profile. Dr Dias also discusses the regulatory process for approving personalized medical devices, and innovations in the field. This interview took place at the 6th World Congress of the Tissue Engineering and Regenerative Medicine International Society (TERMIS 2021).

Moving forward in the field of surgical implants

Simon Ng — Tue, 18 Jan 2022 18:02:35 +0000

Aylvin Dias, PhD, DSM, Geleen, The Netherlands, discusses improvements that need to be made in the development of surgical implants, including ensuring reproducibility in the manufacturing process and providing traceable documentation with the medical devices. Dr Dias additionally highlights the need to take clinician feedback into account, in terms of biocompatibility and mechanical stress during implantation. This interview took place at the 6th World Congress of the Tissue Engineering and Regenerative Medicine International Society (TERMIS 2021).